Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 33

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 1
Chunk 33
---
 Right-of-use assets, net 
    $869,538  
    $1,464,367 

The operating lease liability
for the operating lease was recorded in the condensed consolidated balance sheets as follows:

     September 30,   December 31,      2025   2024      (Successor)   (Successor)   Operating lease liabilities, current  $931,023   $876,392   Operating lease liabilities, non-current   -    699,107   Total operating lease liabilities  $931,023   $1,575,499                Weighted-average remaining lease term of operating leases (in years)   1.00    1.75   Weighted-average discount rate for operating leases   9.60%   9.60% 

14

The following table reconciles
the undiscounted future minimum lease payments under the non-cancelable operating lease with terms of more than one year to the total
operating lease liabilities recognized on the Company’s balance sheet as of September 30, 2025:

Maturity of the Company’s
lease liabilities as of September 30, 2025 is as follows:

    2025 (remainder of year) 
    $252,415 
  
    2026 
     726,394 
  
    Total lease payments 
     978,809 
  
    Less: imputed interest 
     (47,786)
  
    Total lease liabilities 
    $931,023 

NOTE 8 – STOCKHOLDERS’
DEFICIT

Successor Series A Convertible Preferred Stock

The Company designated 12,580
shares of its authorized preferred stock as the Series A Preferred Stock and the rights, preferences and privileges of the Series A Preferred
Stock are summarized below.

Each share of Series A Preferred
Stock has a stated value of $1,000 per share and, when issued, the Series A Preferred Stock was fully paid and non-assessable. The Series
A Preferred Stock, ranks senior to all other Company capital stock unless required holder votes are obtained to create a class of stock
senior to Series A Preferred Stock. The requisite holders of Series A Preferred Stock consented to the issuance of the Series C Preferred
Stock and Series D Preferred Stock, each as described below, which ranks senior to the Series A Preferred Stock and Series B Preferred